Home > Boards > US OTC > Biotechs >

Sangamo Biosciences Inc. (SGMO)

SGMO RSS Feed
Add SGMO Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 12/12/2019 6:18:02 PM - Followers: 77 - Board type: Free - Posts Today: 0

http://www.sangamo.com/index.php

http://finance.yahoo.com/q/ks?s=SGMO+Key+Statistics

Sangamo Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on translating ground-breaking science into genomic therapies that transform patients' lives using platform technologies in genome editing, gene therapy, gene regulation, and cell therapy. The company?s proprietary zinc finger DNA-binding protein (ZFP) technology enables specific genome editing and gene regulation. The ZFPs could be engineered to make ZFP nucleases (ZFNs), proteins that could be used to specifically modify DNA sequences by adding or knocking out specific genes; and ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off. Its therapeutic products include SB-728-T, a ZFN-mediated autologous T-cell product for human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS), which is in Phase II and Phase I clinical trials; and SB-728-HSPC that is in Phase I/II clinical trials for HIV/AIDS. The company also engages in Phase I/II studies of in vivo genome editing applications of ZFP Therapeutics for hemophilia B, Hemophilia A, and Mucopolysaccharidosis I (MPS) and MPS II, which are lysosomal storage disorder (LSD); proprietary preclinical programs in other LSDs; and research stage programs in certain central nervous system disorders and cancer immunotherapies. It has collaborative partnerships with Biogen Inc. to develop therapeutic genome editing products in hemoglobinopathies; and with Shire International GmbH to develop the preclinical development program in Huntington?s disease, as well as license agreement with Sigma-Aldrich Corporation to develop ZFP-based laboratory research reagents and Dow AgroSciences, LLC to modify the genomes or alter protein expression of plant cells, plants, or plant cell cultures. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was founded in 1995 and is headquartered in Richmond, California.

 

SGMO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SGMO News: Schedule 13g 01/28/2020 11:05:19 AM
SGMO News: Sangamo Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference 01/09/2020 08:30:00 AM
SGMO News: Current Report Filing (8-k) 12/23/2019 08:04:05 AM
SGMO News: Sangamo Announces Early Completion of Transfer to Pfizer of SB-525 Hemophilia A Gene Therapy IND & an Earned $25 Million Mile... 12/23/2019 06:50:00 AM
SGMO News: Sangamo Highlights Advancements in Genomic Medicine Pipeline and Expanded R&D and Manufacturing Capabilities at R&D Day 12/17/2019 06:45:00 AM
PostSubject
#347   IMO they'd (PFE) be getting a steal at ByMorStock 12/12/19 06:18:02 PM
#346   SGMO Some coments in stocktwits about PFIZER BUYOUT CHARLIE125 12/12/19 03:20:27 PM
#345   Unfortunately The CEO and the IR/PR dude need to ByMorStock 12/10/19 03:43:53 PM
#344   well, that was a big fizzle. jbaxter 12/10/19 03:16:57 PM
#343   Awesome background on ASH and SGMO here ByMorStock 12/08/19 06:15:22 PM
#342   "Top Notch Program, Platform and Leadership ByMorStock 12/08/19 04:00:46 PM
#341   SGMO and PFE HUGE News on Drug Trial ByMorStock 12/07/19 01:54:33 PM
#340   TA of SGMO https://msmoneymoves.com/2019/07/08/sangamo-therapeutics-inc-nasdaq-s Zmill 07/13/19 09:05:47 AM
#339   Good stuff, thanks roadkilll 07/10/19 09:35:06 PM
#338   Are you reading the other SGMO site I ciciagt 07/09/19 01:56:19 PM
#337   Market really doesn't like Sangamo's PR history roadkilll 07/09/19 11:11:18 AM
#336   Biomarin needs to go commercial as soon as possible roadkilll 07/08/19 09:42:18 PM
#335   Sangamo has begun the tech transfer for the roadkilll 07/08/19 09:29:09 PM
#334   “Jefferies: SGMO providing reasons for pts+docs to hesitate ciciagt 07/08/19 07:23:27 PM
#333   “WF - SGMO: Hem A Update, Emerging Best-In-Class ciciagt 07/08/19 07:21:11 PM
#332   “BREAKING NEWS - Sangamo (SGMO) - SB-525 Looks ciciagt 07/08/19 07:19:45 PM
#329   * * $SGMO Video Chart 07-08-2019 * * ClayTrader 07/08/19 04:10:56 PM
#328   $11.50, raised $145 million roadkilll 07/08/19 04:02:01 PM
#326   RICHMOND, Calif., April 3, 2019 /PRNewswire/ -- Sangamo ciciagt 04/03/19 11:17:14 PM
#325   * * $SGMO Video Chart 04-02-2019 * * ClayTrader 04/02/19 05:23:27 PM
#324   Sangamo price target raised to $34 from $24 ciciagt 04/02/19 10:50:50 AM
#323   ciciagt... Thanks for posting... jessellivermore 04/02/19 09:46:37 AM
#322   “After getting slammed two months ago after rolling ciciagt 04/02/19 09:38:40 AM
#321   Nice update. I have been intrigued by what steadykickin 03/07/19 11:59:39 AM
#320   Sangamo (SGMO) Fress 03/04/19 06:25:51 PM
#319   * * $SGMO Video Chart 02-07-19 * * ClayTrader 02/07/19 04:54:09 PM
#318   Bought some on the dip today hoping to FXR Guy 02/07/19 02:43:16 PM
#317   You can't hug you children with ZINC fingers ! calluch 09/05/18 10:18:25 AM
#316   Bioverativ & Sangamo Announce FDA Acceptance of IND MyzStreet 05/16/18 05:06:57 PM
#315   This is from the Motley Fool five days King Bolaba 04/13/18 12:54:11 AM
#314   Yes, I also have to thank Zincfinger for King Bolaba 04/13/18 12:42:17 AM
#313   depends on phase trials---$50-100 ?? silkcash 03/12/18 10:38:11 AM
#312   Fill me in guys. What is your 3 JohnCM 03/10/18 06:48:25 PM
#311   Somebody named Zincfingers told KBLB shareholders about this silkcash 02/22/18 05:27:42 PM
#310   BUY and Hold silkcash 01/03/18 04:17:27 PM
#309   https://www.streetinsider.com/dr/news.php?id=13534330&gfv=1 $20.00 target ofthegreenes 11/26/17 04:47:05 PM
#308   If just started to follow it. TREND1 11/24/17 10:16:30 AM
#307   Do you like this stock? ofthegreenes 11/24/17 07:35:49 AM
#306   Earnings Per Share (EPS) =-1.02 TREND1 11/23/17 02:00:11 PM
#305   Profit/Loss = $ -71.66M TREND1 11/23/17 01:59:29 PM
#304   SGMO CCI 10 STO 5,1 TREND1 11/23/17 01:57:35 PM
#303   Third Quarter 2017 Financial Results TREND1 11/23/17 01:49:20 PM
#302   Indeed it is!!!! hentied 11/15/17 06:41:06 PM
#301   Indeed it is!!!! hentied 11/15/17 06:41:00 PM
#300   This is HUGE for both patients and the company! ByMorStock 11/15/17 05:53:58 PM
#299   Sgmo* not sanp Imfranko 10/26/17 08:38:01 AM
#298   Sanp along side another huge upside play frlf Imfranko 10/26/17 08:37:41 AM
#297   BioSciences logoSangamo BioSciences Inc. (NASDAQ:SGMO) was the recipient ofthegreenes 10/26/17 08:08:55 AM
#296   https://sheridandaily.com/the-street-expecting-0-23-per-share-for-sangamo-therap ofthegreenes 10/25/17 10:55:10 AM
#295   $SGMO is currently rated a HOLD and long Triple9 10/24/17 12:55:37 PM
PostSubject